Market Overview

Key Technical Levels Boost La Jolla Pharmaceutical 18% Higher

Related LJPC
Oppenheimer Is Excited About These 3 Biotech Stocks
La Jolla Pharmaceutical Company Announces Initiation of Phase 3 Clinical Trial of LJPC-501 in Catecholamine-Resistant Hypotension

La Jolla Pharmaceutical (NASDAQ: LJPC) jumped following a heavy technical level.

Since early June, the stock price traded in a slightly horizontal range from $9.06 to $9.20, followed by a short dip to $8.23 reversing to $9.01. During its short recovery, the price completely dismissed its expected retracement back to the $9.20 range, surging upward Friday afternoon.

The stock was last trading at $10.65, up 18.9 percent.

Posted-In: Movers


Related Articles (LJPC)

Around the Web, We're Loving...